ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Drugs Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-6M12952
Home | Market Reports | Science| Biological Sciences
Global Nucleic Acid Drugs Market Size Status and Forecast 2022 2028
BUY CHAPTERS

Global Nucleic Acid Drugs Market Research Report 2025

Code: QYRE-Auto-6M12952
Report
March 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
BioNTech
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Mina Therapeutics
Biogen
SOBI
Novartis
Pfizer Inc
Jazz Pharmaceuticals
ProQR
Secarna
Sylentis
Arrowhead
Silence Therapeutics
Dicerna

Nucleic Acid Drugs Market Size

The global market for Nucleic Acid Drugs was valued at US$ 12900 million in the year 2024 and is projected to reach a revised size of US$ 16590 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Nucleic Acid Drugs Market

Major Trends 

The nucleic acid drugs market grows as advances in biotechnology and gene therapy transform modern medicine. These drugs, including RNA and DNA-based therapeutics, enable precise treatment of genetic and infectious diseases. Pharmaceutical companies invest heavily in research to develop stable delivery platforms that ensure targeted action with minimal side effects. Rising awareness of personalized medicine and rare disease treatment expands clinical applications. Collaborations between biotech firms and academic institutions accelerate discovery and clinical translation. With their potential to address previously untreatable conditions, nucleic acid drugs represent a cornerstone of next-generation therapeutic development.

Nucleic Acid Drugs Market Trends

A major trend is the increasing use of lipid and polymer-based delivery systems to protect nucleic acids during transport. These carriers enhance bioavailability and tissue targeting, reducing degradation within biological environments. Continuous refinement of these formulations drives broader adoption across therapeutic pipelines.

Another trend involves the expansion of contract manufacturing partnerships to meet global demand. Pharmaceutical companies collaborate with specialized production firms to scale up formulation and quality-control capabilities efficiently. This networked manufacturing approach ensures faster market readiness for novel therapies.

The third trend centers on regulatory harmonization efforts. Authorities streamline approval pathways for advanced therapies, providing clearer guidance on safety and efficacy evaluation. This collaborative framework encourages innovation and boosts investor confidence in nucleic acid drug development.

Nucleic Acid Drugs Market Share

In North America, market share is strengthened by strong research funding and clinical trial infrastructure. The region leads in early-stage development of RNA-based therapies, supported by collaborations between pharmaceutical giants and biotech innovators. High adoption of personalized medicine accelerates growth.

In Asia-Pacific, expanding biopharmaceutical capacity supports production and clinical testing of nucleic acid therapies. Governments encourage investment in advanced biotechnology sectors, fostering partnerships between research institutes and private firms. This strategic growth strengthens regional competitiveness in global therapeutics.

Scope of Nucleic Acid Drugs Market Report

Report Metric Details
Report Name Nucleic Acid Drugs Market
Accounted market size in year US$ 12900 million
Forecasted market size in 2031 US$ 16590 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Antisense Oligonucleotides (ASO)
  • siRNA
  • mRNA
Segment by Application
  • Neuromuscular Diseases
  • hATTR
  • COVID-19
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Nucleic Acid Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nucleic Acid Drugs Market growing?

Ans: The Nucleic Acid Drugs Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Nucleic Acid Drugs Market size in 2031?

Ans: The Nucleic Acid Drugs Market size in 2031 will be US$ 16590 million.

What is the market share of major companies in Nucleic Acid Drugs Market?

Ans: These global top five players had a share approximately 98% in terms of revenue.

Who are the main players in the Nucleic Acid Drugs Market report?

Ans: The main players in the Nucleic Acid Drugs Market are Sarepta Therapeutics, Ionis Pharmaceuticals, Alnylam, Biogen, Nippon Shinyaku, Sobi, Novartis, BioNTech, Pfizer, Moderna Therapeutics, Jazz Pharmaceuticals, CureVac, Regulus Therapeutics, ProQR, Secarna, MiNA Therapeutics, Sylentis, Arrowhead, Silence Therapeutics, Dicerna

What are the Application segmentation covered in the Nucleic Acid Drugs Market report?

Ans: The Applications covered in the Nucleic Acid Drugs Market report are Neuromuscular Diseases, hATTR, COVID-19, Other

What are the Type segmentation covered in the Nucleic Acid Drugs Market report?

Ans: The Types covered in the Nucleic Acid Drugs Market report are Antisense Oligonucleotides (ASO), siRNA, mRNA

Recommended Reports

Nucleic Acid Therapies

Gene Therapy Markets

Nucleic Acid Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antisense Oligonucleotides (ASO)
1.2.3 siRNA
1.2.4 mRNA
1.3 Market by Application
1.3.1 Global Nucleic Acid Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neuromuscular Diseases
1.3.3 hATTR
1.3.4 COVID-19
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Drugs Market Perspective (2020-2031)
2.2 Global Nucleic Acid Drugs Growth Trends by Region
2.2.1 Global Nucleic Acid Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nucleic Acid Drugs Historic Market Size by Region (2020-2025)
2.2.3 Nucleic Acid Drugs Forecasted Market Size by Region (2026-2031)
2.3 Nucleic Acid Drugs Market Dynamics
2.3.1 Nucleic Acid Drugs Industry Trends
2.3.2 Nucleic Acid Drugs Market Drivers
2.3.3 Nucleic Acid Drugs Market Challenges
2.3.4 Nucleic Acid Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Drugs Players by Revenue
3.1.1 Global Top Nucleic Acid Drugs Players by Revenue (2020-2025)
3.1.2 Global Nucleic Acid Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Nucleic Acid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nucleic Acid Drugs Revenue
3.4 Global Nucleic Acid Drugs Market Concentration Ratio
3.4.1 Global Nucleic Acid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Drugs Revenue in 2024
3.5 Global Key Players of Nucleic Acid Drugs Head office and Area Served
3.6 Global Key Players of Nucleic Acid Drugs, Product and Application
3.7 Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Drugs Breakdown Data by Type
4.1 Global Nucleic Acid Drugs Historic Market Size by Type (2020-2025)
4.2 Global Nucleic Acid Drugs Forecasted Market Size by Type (2026-2031)
5 Nucleic Acid Drugs Breakdown Data by Application
5.1 Global Nucleic Acid Drugs Historic Market Size by Application (2020-2025)
5.2 Global Nucleic Acid Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nucleic Acid Drugs Market Size (2020-2031)
6.2 North America Nucleic Acid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nucleic Acid Drugs Market Size by Country (2020-2025)
6.4 North America Nucleic Acid Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nucleic Acid Drugs Market Size (2020-2031)
7.2 Europe Nucleic Acid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nucleic Acid Drugs Market Size by Country (2020-2025)
7.4 Europe Nucleic Acid Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Drugs Market Size (2020-2031)
8.2 Asia-Pacific Nucleic Acid Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nucleic Acid Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Nucleic Acid Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nucleic Acid Drugs Market Size (2020-2031)
9.2 Latin America Nucleic Acid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nucleic Acid Drugs Market Size by Country (2020-2025)
9.4 Latin America Nucleic Acid Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Drugs Market Size (2020-2031)
10.2 Middle East & Africa Nucleic Acid Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nucleic Acid Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Nucleic Acid Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Business Overview
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Introduction
11.1.4 Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
11.1.5 Sarepta Therapeutics Recent Development
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Business Overview
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Introduction
11.2.4 Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)
11.2.5 Ionis Pharmaceuticals Recent Development
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Business Overview
11.3.3 Alnylam Nucleic Acid Drugs Introduction
11.3.4 Alnylam Revenue in Nucleic Acid Drugs Business (2020-2025)
11.3.5 Alnylam Recent Development
11.4 Biogen
11.4.1 Biogen Company Details
11.4.2 Biogen Business Overview
11.4.3 Biogen Nucleic Acid Drugs Introduction
11.4.4 Biogen Revenue in Nucleic Acid Drugs Business (2020-2025)
11.4.5 Biogen Recent Development
11.5 Nippon Shinyaku
11.5.1 Nippon Shinyaku Company Details
11.5.2 Nippon Shinyaku Business Overview
11.5.3 Nippon Shinyaku Nucleic Acid Drugs Introduction
11.5.4 Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2020-2025)
11.5.5 Nippon Shinyaku Recent Development
11.6 Sobi
11.6.1 Sobi Company Details
11.6.2 Sobi Business Overview
11.6.3 Sobi Nucleic Acid Drugs Introduction
11.6.4 Sobi Revenue in Nucleic Acid Drugs Business (2020-2025)
11.6.5 Sobi Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Nucleic Acid Drugs Introduction
11.7.4 Novartis Revenue in Nucleic Acid Drugs Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 BioNTech
11.8.1 BioNTech Company Details
11.8.2 BioNTech Business Overview
11.8.3 BioNTech Nucleic Acid Drugs Introduction
11.8.4 BioNTech Revenue in Nucleic Acid Drugs Business (2020-2025)
11.8.5 BioNTech Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Nucleic Acid Drugs Introduction
11.9.4 Pfizer Revenue in Nucleic Acid Drugs Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Moderna Therapeutics
11.10.1 Moderna Therapeutics Company Details
11.10.2 Moderna Therapeutics Business Overview
11.10.3 Moderna Therapeutics Nucleic Acid Drugs Introduction
11.10.4 Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
11.10.5 Moderna Therapeutics Recent Development
11.11 Jazz Pharmaceuticals
11.11.1 Jazz Pharmaceuticals Company Details
11.11.2 Jazz Pharmaceuticals Business Overview
11.11.3 Jazz Pharmaceuticals Nucleic Acid Drugs Introduction
11.11.4 Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025)
11.11.5 Jazz Pharmaceuticals Recent Development
11.12 CureVac
11.12.1 CureVac Company Details
11.12.2 CureVac Business Overview
11.12.3 CureVac Nucleic Acid Drugs Introduction
11.12.4 CureVac Revenue in Nucleic Acid Drugs Business (2020-2025)
11.12.5 CureVac Recent Development
11.13 Regulus Therapeutics
11.13.1 Regulus Therapeutics Company Details
11.13.2 Regulus Therapeutics Business Overview
11.13.3 Regulus Therapeutics Nucleic Acid Drugs Introduction
11.13.4 Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
11.13.5 Regulus Therapeutics Recent Development
11.14 ProQR
11.14.1 ProQR Company Details
11.14.2 ProQR Business Overview
11.14.3 ProQR Nucleic Acid Drugs Introduction
11.14.4 ProQR Revenue in Nucleic Acid Drugs Business (2020-2025)
11.14.5 ProQR Recent Development
11.15 Secarna
11.15.1 Secarna Company Details
11.15.2 Secarna Business Overview
11.15.3 Secarna Nucleic Acid Drugs Introduction
11.15.4 Secarna Revenue in Nucleic Acid Drugs Business (2020-2025)
11.15.5 Secarna Recent Development
11.16 MiNA Therapeutics
11.16.1 MiNA Therapeutics Company Details
11.16.2 MiNA Therapeutics Business Overview
11.16.3 MiNA Therapeutics Nucleic Acid Drugs Introduction
11.16.4 MiNA Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
11.16.5 MiNA Therapeutics Recent Development
11.17 Sylentis
11.17.1 Sylentis Company Details
11.17.2 Sylentis Business Overview
11.17.3 Sylentis Nucleic Acid Drugs Introduction
11.17.4 Sylentis Revenue in Nucleic Acid Drugs Business (2020-2025)
11.17.5 Sylentis Recent Development
11.18 Arrowhead
11.18.1 Arrowhead Company Details
11.18.2 Arrowhead Business Overview
11.18.3 Arrowhead Nucleic Acid Drugs Introduction
11.18.4 Arrowhead Revenue in Nucleic Acid Drugs Business (2020-2025)
11.18.5 Arrowhead Recent Development
11.19 Silence Therapeutics
11.19.1 Silence Therapeutics Company Details
11.19.2 Silence Therapeutics Business Overview
11.19.3 Silence Therapeutics Nucleic Acid Drugs Introduction
11.19.4 Silence Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025)
11.19.5 Silence Therapeutics Recent Development
11.20 Dicerna
11.20.1 Dicerna Company Details
11.20.2 Dicerna Business Overview
11.20.3 Dicerna Nucleic Acid Drugs Introduction
11.20.4 Dicerna Revenue in Nucleic Acid Drugs Business (2020-2025)
11.20.5 Dicerna Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sarepta Therapeutics
Ionis Pharmaceuticals
Alnylam
BioNTech
Nippon Shinyaku
Moderna Therapeutics
CureVac
Regulus Therapeutics
Mina Therapeutics
Biogen
SOBI
Novartis
Pfizer Inc
Jazz Pharmaceuticals
ProQR
Secarna
Sylentis
Arrowhead
Silence Therapeutics
Dicerna
List of Tables
 Table 1. Global Nucleic Acid Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antisense Oligonucleotides (ASO)
 Table 3. Key Players of siRNA
 Table 4. Key Players of mRNA
 Table 5. Global Nucleic Acid Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Nucleic Acid Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Nucleic Acid Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Nucleic Acid Drugs Market Share by Region (2020-2025)
 Table 9. Global Nucleic Acid Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Nucleic Acid Drugs Market Share by Region (2026-2031)
 Table 11. Nucleic Acid Drugs Market Trends
 Table 12. Nucleic Acid Drugs Market Drivers
 Table 13. Nucleic Acid Drugs Market Challenges
 Table 14. Nucleic Acid Drugs Market Restraints
 Table 15. Global Nucleic Acid Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Nucleic Acid Drugs Market Share by Players (2020-2025)
 Table 17. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2024)
 Table 18. Ranking of Global Top Nucleic Acid Drugs Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Nucleic Acid Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Nucleic Acid Drugs, Headquarters and Area Served
 Table 21. Global Key Players of Nucleic Acid Drugs, Product and Application
 Table 22. Global Key Players of Nucleic Acid Drugs, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Nucleic Acid Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Nucleic Acid Drugs Revenue Market Share by Type (2020-2025)
 Table 26. Global Nucleic Acid Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Nucleic Acid Drugs Revenue Market Share by Type (2026-2031)
 Table 28. Global Nucleic Acid Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Nucleic Acid Drugs Revenue Market Share by Application (2020-2025)
 Table 30. Global Nucleic Acid Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Nucleic Acid Drugs Revenue Market Share by Application (2026-2031)
 Table 32. North America Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Nucleic Acid Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Nucleic Acid Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Nucleic Acid Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Nucleic Acid Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Nucleic Acid Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Nucleic Acid Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Nucleic Acid Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Nucleic Acid Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Nucleic Acid Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Sarepta Therapeutics Company Details
 Table 48. Sarepta Therapeutics Business Overview
 Table 49. Sarepta Therapeutics Nucleic Acid Drugs Product
 Table 50. Sarepta Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 51. Sarepta Therapeutics Recent Development
 Table 52. Ionis Pharmaceuticals Company Details
 Table 53. Ionis Pharmaceuticals Business Overview
 Table 54. Ionis Pharmaceuticals Nucleic Acid Drugs Product
 Table 55. Ionis Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 56. Ionis Pharmaceuticals Recent Development
 Table 57. Alnylam Company Details
 Table 58. Alnylam Business Overview
 Table 59. Alnylam Nucleic Acid Drugs Product
 Table 60. Alnylam Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 61. Alnylam Recent Development
 Table 62. Biogen Company Details
 Table 63. Biogen Business Overview
 Table 64. Biogen Nucleic Acid Drugs Product
 Table 65. Biogen Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 66. Biogen Recent Development
 Table 67. Nippon Shinyaku Company Details
 Table 68. Nippon Shinyaku Business Overview
 Table 69. Nippon Shinyaku Nucleic Acid Drugs Product
 Table 70. Nippon Shinyaku Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 71. Nippon Shinyaku Recent Development
 Table 72. Sobi Company Details
 Table 73. Sobi Business Overview
 Table 74. Sobi Nucleic Acid Drugs Product
 Table 75. Sobi Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 76. Sobi Recent Development
 Table 77. Novartis Company Details
 Table 78. Novartis Business Overview
 Table 79. Novartis Nucleic Acid Drugs Product
 Table 80. Novartis Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 81. Novartis Recent Development
 Table 82. BioNTech Company Details
 Table 83. BioNTech Business Overview
 Table 84. BioNTech Nucleic Acid Drugs Product
 Table 85. BioNTech Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 86. BioNTech Recent Development
 Table 87. Pfizer Company Details
 Table 88. Pfizer Business Overview
 Table 89. Pfizer Nucleic Acid Drugs Product
 Table 90. Pfizer Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 91. Pfizer Recent Development
 Table 92. Moderna Therapeutics Company Details
 Table 93. Moderna Therapeutics Business Overview
 Table 94. Moderna Therapeutics Nucleic Acid Drugs Product
 Table 95. Moderna Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 96. Moderna Therapeutics Recent Development
 Table 97. Jazz Pharmaceuticals Company Details
 Table 98. Jazz Pharmaceuticals Business Overview
 Table 99. Jazz Pharmaceuticals Nucleic Acid Drugs Product
 Table 100. Jazz Pharmaceuticals Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 101. Jazz Pharmaceuticals Recent Development
 Table 102. CureVac Company Details
 Table 103. CureVac Business Overview
 Table 104. CureVac Nucleic Acid Drugs Product
 Table 105. CureVac Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 106. CureVac Recent Development
 Table 107. Regulus Therapeutics Company Details
 Table 108. Regulus Therapeutics Business Overview
 Table 109. Regulus Therapeutics Nucleic Acid Drugs Product
 Table 110. Regulus Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 111. Regulus Therapeutics Recent Development
 Table 112. ProQR Company Details
 Table 113. ProQR Business Overview
 Table 114. ProQR Nucleic Acid Drugs Product
 Table 115. ProQR Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 116. ProQR Recent Development
 Table 117. Secarna Company Details
 Table 118. Secarna Business Overview
 Table 119. Secarna Nucleic Acid Drugs Product
 Table 120. Secarna Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 121. Secarna Recent Development
 Table 122. MiNA Therapeutics Company Details
 Table 123. MiNA Therapeutics Business Overview
 Table 124. MiNA Therapeutics Nucleic Acid Drugs Product
 Table 125. MiNA Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 126. MiNA Therapeutics Recent Development
 Table 127. Sylentis Company Details
 Table 128. Sylentis Business Overview
 Table 129. Sylentis Nucleic Acid Drugs Product
 Table 130. Sylentis Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 131. Sylentis Recent Development
 Table 132. Arrowhead Company Details
 Table 133. Arrowhead Business Overview
 Table 134. Arrowhead Nucleic Acid Drugs Product
 Table 135. Arrowhead Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 136. Arrowhead Recent Development
 Table 137. Silence Therapeutics Company Details
 Table 138. Silence Therapeutics Business Overview
 Table 139. Silence Therapeutics Nucleic Acid Drugs Product
 Table 140. Silence Therapeutics Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 141. Silence Therapeutics Recent Development
 Table 142. Dicerna Company Details
 Table 143. Dicerna Business Overview
 Table 144. Dicerna Nucleic Acid Drugs Product
 Table 145. Dicerna Revenue in Nucleic Acid Drugs Business (2020-2025) & (US$ Million)
 Table 146. Dicerna Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Nucleic Acid Drugs Picture
 Figure 2. Global Nucleic Acid Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Nucleic Acid Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antisense Oligonucleotides (ASO) Features
 Figure 5. siRNA Features
 Figure 6. mRNA Features
 Figure 7. Global Nucleic Acid Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Nucleic Acid Drugs Market Share by Application: 2024 VS 2031
 Figure 9. Neuromuscular Diseases Case Studies
 Figure 10. hATTR Case Studies
 Figure 11. COVID-19 Case Studies
 Figure 12. Other Case Studies
 Figure 13. Nucleic Acid Drugs Report Years Considered
 Figure 14. Global Nucleic Acid Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Nucleic Acid Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Nucleic Acid Drugs Market Share by Region: 2024 VS 2031
 Figure 17. Global Nucleic Acid Drugs Market Share by Players in 2024
 Figure 18. Global Top Nucleic Acid Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Drugs as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Nucleic Acid Drugs Revenue in 2024
 Figure 20. North America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Nucleic Acid Drugs Market Share by Country (2020-2031)
 Figure 22. United States Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Nucleic Acid Drugs Market Share by Country (2020-2031)
 Figure 26. Germany Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Nucleic Acid Drugs Market Share by Region (2020-2031)
 Figure 34. China Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Nucleic Acid Drugs Market Share by Country (2020-2031)
 Figure 42. Mexico Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Nucleic Acid Drugs Market Share by Country (2020-2031)
 Figure 46. Turkey Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Nucleic Acid Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 50. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 51. Alnylam Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 52. Biogen Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 53. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 54. Sobi Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 55. Novartis Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 56. BioNTech Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 57. Pfizer Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 58. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 60. CureVac Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 61. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 62. ProQR Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 63. Secarna Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 64. MiNA Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 65. Sylentis Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 66. Arrowhead Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 67. Silence Therapeutics Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 68. Dicerna Revenue Growth Rate in Nucleic Acid Drugs Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Nucleic Acid Therapeutic Market Research Report 2024
Global RNA based Therapeutics Drug Market Research Report 2024
Global Nucleic acid based Therapeutics Drug Market Research Report 2024
Global Nucleic Acid based Therapy Market Research Report 2024
Global Nucleic Acid Medicine Market Research Report 2025
Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024
Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025
Global ASO based Drug Market Research Report 2024
Global RNA Therapeutics Market Research Report 2024
Global Small Interfering RNA siRNA Drugs Market Research Report 2024
Global Antisense Oligonucleotides ASO Therapy Market Research Report 2024
Global Oligonucleotide Oligo Drugs Market Research Report 2024
Global Oligonucleotide Drugs ONs Market Research Report 2025
Global Antisense Oligonucleotides based Therapeutics Market Research Report 2024
Global Small Nucleic Acid Drug Market Research Report 2025
Global Nucleic Acid Based Gene Therapy Market Research Report 2025
Antisense and RNAi Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNA Interference RNAi Based Therapeutics Market Research Report 2024
Global Oligonucleotide Therapeutics Market Research Report 2024
Global Antisense Oligonucleotide Therapy for the Nervous System Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions